Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor site/version maintenance update rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history list. This update affects only the revision history entries on the page and does not alter study data or functionality.SummaryDifference0.1%

- Check80 days agoChange DetectedAddition of Revision: v3.4.2 and the removal of the funding/operating status notice are site-wide administrative updates. They do not change the study record, its data, or the core content of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check87 days agoChange DetectedAdded a government funding status notice and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.6%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.